DOI: 10.1093/braincomms/fcad235 ISSN:

Facioscapulohumeral muscular dystrophy’s game of homeodomains: therapy wants a biomarker as a sword wants a whetstone

Michael Kyba, Darko Bosnakovski
  • Neurology
  • Cellular and Molecular Neuroscience
  • Biological Psychiatry
  • Psychiatry and Mental health

This scientific commentary refers to ‘The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy’, by Banerji et al. (

More from our Archive